Abstract:Aim Lymphoepithelioma-like carcinoma (LELC) is a rare histological types of solid tumors. The present study aims to comprehensively describe the demographic and clinical features of LELC using surveillance, epidemiology, and end results (SEER) database, with an emphasis on the prognostic difference according to primary tumor sites of LELC. Materials and methods A population cohort with histologically diagnosed LELC were identified from SEER database between 1973 and 2016. Age-adjusted incidence rates and cancer-specific survival (CSS) were determined. Cox-regression proportional hazards model was used for both univariate and multivariate analyses. Results In total, 2106 patients with LELC were identified, with the most common diagnosed primary tumor site of nasopharyngeal LELC (56.22%), followed by non-nasopharyngeal head and neck LELC (21.32%) and respiratory system (7.83%). The overall age-adjusted incidence of LELC was 0.091 per 100,000. The CSS rates of LELC patients at 5, 10, 15, and 20 years were 76%, 69%, 65%, and 61%, respectively. A tendency of decreasing incidence of LELC was observed in the past decade. Univariate analysis indicated that sex [hazard ratio (HR) 1.21, p = 0.031], year of diagnosis (HR 0.60 and 0.63, p < 0.001), race (HR 1.29, p = 0.0021), age (HR 1.25, p = 0.0072), summary tumor stage (HR 1.97, and 4.57, both p < 0.001), number of positive LN(HR2.21, p < 0.001), surgery (HR 0.58, p = 0.0033), chemotherapy (HR 1.19, p = 0.037) and primary tumor site (p < 0.001) were significant factors associated with prognosis of LELC. In multivariate analysis, age (HR 1.75, p = 0.03), distant stage (HR 6.57, p = 0.0001), number of positive LN (HR 2.63, p = 0.0015) and non-nasopharyngeal head and neck LELC (HR 0.37, p = 0.0031) were significantly independent predictors for CSS of LELC. In sub-group analysis, radiotherapy significantly improves CSS for nasopharyngeal LELC (HR 0.57, p = 0.0002), while surgery significantly improve CSS for non-nasopharyngeal LELC (HR 0.33, p < 0.0001). Conclusion Based on SEER data analysis, age older than 50 years, distant stage and more than three positive LN are significantly associated with worse CSS for LELC, while the prognosis of non-nasopharyngeal head and neck LELC is significantly better than nasopharyngeal LELC. Local treatments for LELC could be recommended according to primary tumor sites.

Clinical characteristics, prognostic factors, and treatment modalities for head and neck lymphoepithelioma-like carcinoma: A real-world study from southern China

Clinical features and treatment outcome of lymphoepithelioma-like carcinoma from multiple primary sites: a population-based, multicentre, real-world study

Clinical outcomes of non-nasopharyngeal lymphoepithelial carcinoma treated with a combined modality approach: A single-institution study

Clinical treatment strategy and follow-up of lymphoepithelioma-like carcinoma: a retrospective study

Surgical Treatment of Epstein-Barr Virus–associated Lymphoepithelioma-Like Carcinoma Occurring in Both the Posterior Mediastinum and Liver

Epidemiology and Prognosis of Lymphoepithelioma-Like Carcinoma: a Comprehensive Analysis of Surveillance, Epidemiology, and End Results (SEER) Database

Lymphoepithelial carcinoma of the head and neck: a SEER analysis of prognostic factors for survival

The Treatment of Primary Lymphoepithelioma‐Like Carcinoma in the Head and Neck and Nasopharyngeal Carcinoma

Cliulcul Analysis of Primary Lymphoepithelioma-Like Carcinoma of the Lung

Analysis of 9 Cases of Primary Lymphoepithelioma-like Carcinoma of the Lung and Review of Literatures

Clinical observation of pulmonary lymphoepithelioma-like carcinoma

Multimodality treatment and long-term follow-up of the primary pulmonary lymphoepithelioma-like carcinoma

Primary lymphoepithelioma-like carcinoma of the lung: An unusual cancer and clinical outcomes of 14 patients

Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection

Thorough survey and analysis of pulmonary lymphoepithelioma-like carcinoma in Macau and multimodality treatment for advanced disease

Primary pulmonary lymphoepithelioma-like carcinoma: fifty-two patients with long-term follow-up.

First-line platinum-based chemotherapy and survival outcomes in locally advanced or metastatic pulmonary lymphoepithelioma-like carcinoma

Clinicopathological Characteristics with EGFR, ALK, ROS1 Genetic Alternation and Prognostic Analysis of Primary Lymphoepithelioma-Like Carcinoma

Advanced primary pulmonary lymphoepithelioma-like carcinoma: clinical manifestations, treatment, and outcome

A Clinical Analysis of 37 Cases with Lymphoepithelial Carcinoma of the Major Salivary Gland Treated by Surgical Resection and Postoperative Radiotherapy: a Single Institution Study.

Neoadjuvant immunotherapy in patients with pulmonary lymphoepithelioma-like carcinoma